As Chief Editor of one of the two journals in which Biopharma Dealmakers appears, I have a keen interest in the process of translating biomedical research into new drugs, including the partnerships ...

The use of oligonucleotides as therapeutic agents is of great interest, particularly when it comes to siRNA and antisense oligonucleotides. However, the difficulty of targeting the right organ and ...

Oligonucleotide therapeutics make up a small but rapidly growing segment of the overall global drug pipeline, with 245 programs currently in development today. While only one approved oligo ...

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the release of its MassHunter BioConfirm 12.0 software, which now supports data generated by Agilent ...

Knowledge of gene function is required to utilize sequence information to develop new drugs to treat disease. In vitro techniques, such as antisense oligonucleotides (AS-ODNs) 1,2,3, ribozymes 4,5, ...

Antisense oligonucleotide (ASO) therapy has the potential to ameliorate many neurodegenerative diseases at the genetic level to suppress the production of harmful proteins or non-coding RNAs.

GSK has added another oligonucleotide to its pipeline, with potentially plenty more to follow courtesy of a $170 million upfront collaboration with Wave Life Sciences. As part of the deal, GSK will ...

- The next frontier in oligonucleotide synthesis is the direct synthesis of gene-length sequences. - Ansa synthesized a 1005 base long oligonucleotide with industry-leading accuracy. - Ansa will be ...

Creyon Bio, an oligonucleotide research specialist with the goal of designing precision medicines, has emerged with $40 million from a series A financing round led by DCVC Bio and Lux Capital. Creyon ...

In recent years, techniques have been developed to treat diseases with what are known as oligonucleotide drugs, based on short DNA or RNA molecules. The Wallenberg Centre for Molecular and ...

Dublin, Jan. 19, 2026 (GLOBE NEWSWIRE) -- The "Oligonucleotide CDMO Market Size, Share & Trends Analysis Report by Service (Contract Development, Contract Manufacturing), Type (Antisense ...

Avidity Biosciences, Inc.'s stock surged ~650% in the past year, driven by positive developments in its Antibody Oligonucleotide Conjugates (AOCs) for muscular disorders. Key catalysts include a ...